Speed, Quality & Cost – Why You Should Be Conducting Your Clinical Trials in Australia (WS22)

30 April 2019
Available Seats:

Over the last 20 years Australia has grown to become a destination of choice for the conduct of early phase clinical trials. Rapid ethics approval and a simple notification to the Therapeutic Goods Administrations (TGA) means that from submission to FPFD it will only take on average 6 weeks.  Coupled with the attractive R&D tax incentive program offered by the Australian Government this swift to study data can then be used to support an IND or IMPD application allowing companies to speed up their drug development process

Become a member

Global Clinical Supplies Group

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.